Table 4.
Estimated relative hazard of fracture among past users of oral estrogen
| Menopause Type Hazard Ratio (95% CI) |
||
|---|---|---|
| n=1723 | ||
| Fracture Type | Surgical | Natural |
| (n=366) | (n=1357) | |
| Hip | (n fx=37) | (n fx=166) |
| Unadjusted | 0.98 (0.69–1.40) | 1.00 |
| Multivariable | 0.94 (0.63–1.41) | 1.00 |
| Multivariable+Calc BMD | 0.95 (0.63–1.42) | 1.00 |
| Model n=1566 | ||
| Wrist | (n fx=31) | (n fx=136) |
| Unadjusted | 0.94 (0.64–1.39) | 1.00 |
| Multivariable | 0.78 (0.50–1.23) | 1.00 |
| Multivariable+Dist BMD | 0.84 (0.53–1.33) | 1.00 |
| Model n=1558 | ||
| Any non-vertebral | (n fx=116) | (n fx=512) |
| Unadjusted | 0.90 (0.73–1.10) | 1.00 |
| Multivariable | 0.79 (0.63–0.99) | 1.00 |
| Multivariable+Calc BMD | 0.81 (0.64–1.02) | 1.00 |
| Model n=1438 | ||
Multivariable models adjusted for age, weight, age at menopause, calcium intake (supplement), pack-years smoking, number breastfed, self-reported health status, duration of oral estrogen use, benzodiazepine use, depth perception, contrast sensitivity